Advertisement
Evolocumab
Specialty Drug

Repatha

EVOLOCUMAB is known as a PCSK9 inhibitor. It is used to lower the level of cholesterol in the blood. This medicine is only for patients whose cholesterol is not controlled by diet and other cholesterol-lowering therapy. Compare PCSK9 inhibitors.
Advertisement

Evolocumab Latest News

Get the latest updates on this drug from the GoodRx medical team

Top 10 New Drugs of 2015

Dr. Sharon Orrange - November 16, 2015

Pharmaceutical manufacturers released a number of new prescription drugs in 2015. Some of these new drugs are truly lifesavers . . . and some aren’t. Either way, pharmaceutical companies will be spending lots of money to let you know about them—you’ll be seeing them on the sides of buses and in TV commercials for quite a while.

As a doctor, I’m always excited about improvements that help patients. Some of the drugs below can really make a difference. See More

New Cholesterol-Lowering Drugs Now Approved

Elizabeth Davis - August 31, 2015

In July 2015, Praluent (alirocumab) was approved by the FDA as the first drug in a new class known as PCSK9 inhibitors. It was joined by Repatha (evolocumab), which received approval on August 27, 2015. These new injectable medications are the first approvals in a long time that may be as effective as statins—or better—at lowering cholesterol.

For now, Praluent is only approved for use in two types of people with high cholesterol. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.